Yuhan Corp - Company Profile
Powered by
All the data and insights you need on Yuhan Corp in one report.
- Save hours of research time and resources with
our up-to-date Yuhan Corp Strategy Report
- Understand Yuhan Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Yuhan Corp (Yuhan) discovers, develops, manufactures and markets pharmaceutical products. The company offers APIs and intermediates for antibiotic, antiviral, antifungal, anti-thrombotic, anti-inflammatory, anti-diabetic and anti-hyperlipidemics. The company offers finished goods for the treatment of hypertension, coronary artery disease, hyperlipidemia, cerebral thrombosis and other diseases. Yuhan provides custom synthesis services for other pharmaceutical and biopharmaceutical companies. It offers active pharmaceutical ingredients (API) and finished products in domestic as well as international market. Yuhan operates R&D and manufacturing facilities in Seoul. The company offers its products and services through its sales and distribution branches. Yuhan is headquartered in Seoul, South Korea.
Yuhan Corp premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
APIs & Intermediates: | Custom Synthesis Service | - |
Levofloxacin Hemihydrate | Supply Chain Management | Viread |
Piperacillin Monohydrate | Trajenta | |
XYZ | XYZ | |
XYZ | XYZ | |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Acquisitions/Mergers/Takeovers | In October, the company acquired a 42% stake in ImmuneOncia Therapeutics Inc. |
2023 | Contracts/Agreements | In April, the company entered into an agreement to acquire 38.9% stake in Progen. |
2022 | Contracts/Agreements | In December, Yuhan Care and KRTL Biotech Inc entered into a memorandum of understanding for the development of industry-differentiated commercial CBD and other cannabinoid based products. |
Competitor Comparison
Key Parameters | Yuhan Corp | GC Corp | Daewoong Pharmaceutical Co Ltd | Huons Global Co Ltd | Yuyu Pharma Inc |
---|---|---|---|---|---|
Headquarters | South Korea | South Korea | South Korea | South Korea | South Korea |
City | Seoul | Yongin | Hwaseong | Seongnam | Jecheon |
State/Province | - | - | - | - | Seoul |
No. of Employees | 1,594 | 170 | 1,256 | 541 | 243 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Wook Je Cho | Chief Executive Officer; President | Executive Board | 2021 | 68 |
Jung Hee Lee | Chairman | Non Executive Board | 2021 | 72 |
Byung Man Lee | Director; Head - Business Management Division; Vice President | Executive Board | - | 65 |
Yoo Jae -cheon | Head- Pharmaceutical Business Division; Managing Director | Executive Board | - | 55 |
Jung Joo -young | Director; Head- Marketing Department | Executive Board | - | 56 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward